DENDREON CORP's ticker is DNDNQ and the CUSIP is 24823Q107. A total of 16 filers reported holding DENDREON CORP in Q4 2014. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2014 | $8,348,000 | -38.1% | 5,796,886 | -1.2% | 0.00% | -50.0% |
Q2 2014 | $13,495,000 | -23.2% | 5,867,267 | -0.1% | 0.00% | -20.0% |
Q1 2014 | $17,562,000 | +3.3% | 5,873,592 | +3.3% | 0.01% | 0.0% |
Q4 2013 | $17,003,000 | +0.1% | 5,686,518 | -2.0% | 0.01% | -16.7% |
Q3 2013 | $16,994,000 | -17.8% | 5,799,910 | +15.6% | 0.01% | -25.0% |
Q2 2013 | $20,678,000 | – | 5,018,989 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
SCOPIA CAPITAL MANAGEMENT LP | 1,824,183 | $2,627,000 | 0.05% |
ARISTEIA CAPITAL, L.L.C. | 1,000,000 | $1,440,000 | 0.05% |
Quotient Investors, LLC | 156,100 | $225,000 | 0.05% |
Spark Investment Management LLC | 208,900 | $300,000 | 0.04% |
WOLVERINE ASSET MANAGEMENT LLC | 26,236 | $2,019,000 | 0.04% |
TANG CAPITAL MANAGEMENT LLC | 55,548 | $80,000 | 0.04% |
Point72 Asset Management, L.P. | 3,000,000 | $4,320,000 | 0.03% |
Tower Research Capital LLC (TRC) | 154,756 | $223,000 | 0.02% |
Adamant Biomedical Investments AG | 50,000 | $72,000 | 0.02% |
A.R.T. Advisors, LLC | 261,266 | $376,000 | 0.02% |